For some patients, switching from injected semaglutide to oral semaglutide, or from semaglutide to tirzepatide, offers a different side effect profile that works better with their lifestyle
The disease affects approximately 1 million adults in the United States, according to the National MS Society, with varying clinical presentations including relapsing-remitting MS (RRMS), secondary progressive MS (SPMS), and primary progressive MS (PPMS)
[1] [2] These effects occur because GLP-1 receptor agonists slow gastric emptying and affect gut motility
OASIS 4 also found that oral Wegovy significantly outperformed placebo, cutting an average of 13.6% of participants weight, as opposed to 2.4% in the control group
(Updated March 20, 2023)
Storage: Lyophilized: store at 20 C (4 F)